• PPT (Propyl Pyrazole Triol): Advancing ERα-Selective Sign...

  2025-10-23

  Explore how PPT (Propyl Pyrazole Triol), a selective ERα agonist, is revolutionizing hormone receptor research and biomarker systems biology. This article uniquely dissects the molecular mechanism, translational applications, and systems-level modeling enabled by PPT for estrogen receptor alpha signaling.

• PPT: Selective ERα Agonist Transforming Hormone Receptor ...

  2025-10-22

  PPT (Propyl Pyrazole Triol) stands out as the gold-standard ERα selective ligand for dissecting estrogen receptor signaling in both cancer and developmental biology. Its robust selectivity and solubility unlock reproducible, high-fidelity results across cell-based and in vivo models, streamlining advanced research in breast cancer, lung adenocarcinoma, and hormone receptor biology.

• Gap26: Dissecting Connexin 43 Blockade in Immune & Vascul...

  2025-10-21

  Explore the advanced scientific mechanisms of Gap26, a leading connexin 43 mimetic peptide, and its unique role as a gap junction blocker peptide in immune modulation and vascular smooth muscle research. This article delves deeper into its translational impact on neuroprotection and inflammation, building beyond existing resources.

168 records 12/12 page Previous First page 上5页 1112